GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 140   

Articles published

GSK 1,552.25 -28.25 (-1.79%)
price chart
Most Recent analysts Ratings: GlaxoSmithKline plc (NYSE:GSK)
GlaxoSmithKline plc (NYSE:GSK) will report its next earnings on Feb 1 - Feb 6 (Est.). The company reported the earnings of $0.85/Share in the last quarter where the estimated EPS by analysts was $0.74/share.
Analyst Activity – Goldman Sachs Group Inc. Reiterates Buy on ...  Market Exclusive
Bollard Group LLC Raises Stake in GlaxoSmithKline PLC (GSK)  The Cerbat Gem
The GlaxoSmithKline PLC (GSK) Position Decreased by Loring Wolcott & Coolidge ...
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA reduced its stake in GlaxoSmithKline PLC (NYSE:GSK) by 0.4% during the third quarter, Holdings Channel reports.
GlaxoSmithKline plc's (GSK) "Buy" Rating Reaffirmed at Bryan, Garnier & Co
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “buy” rating reaffirmed by stock analysts at Bryan, Garnier & Co in a research report issued on Monday.
GlaxoSmithKline plc (GSK) PT Lowered to GBX 1600  The Cerbat Gem
Why I'm bullish on GlaxoSmithKline plc for 2017
I believe GlaxoSmithKline (LSE: GSK) is one of the market's most undervalued and under-appreciated stocks. Over the past year, the company has gone from a business struggling to grow, to projected earnings per share growth of 30% this year and 10% for ...
Analyst Activity – Jefferies Group Reiterates Buy on GlaxoSmithKline PLC (NYSE ...
On 10/26/2016 GlaxoSmithKline PLC announced a dividend of $0.46 with an ex dividend date of 11/2/2016 which will be payable on 1/12/2017.
GlaxoSmithKline plc 23.8% Potential Upside Indicated by Liberum Capital  DirectorsTalk Interviews
EPS Of GlaxoSmithKline PLC (NYSE:GSK) At $0.62
In the looming financial release, the forecasters are expecting GlaxoSmithKline PLC (NYSE:GSK) to post EPS of $0.62 for the quarter.
Stock Mover of the Day: GlaxoSmithKline plc (ADR) Declines Again; Strong ...
The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) is a huge mover today! About 778,716 shares traded hands. GlaxoSmithKline plc (ADR) (NYSE:GSK) has declined 7.25% since June 9, 2016 and is downtrending. It has underperformed by 14.58% the ...
Is GlaxoSmithKline plc(NYSE: GSK), a large market cap stock a smart buy?  The Daily Leicester
Research Report for Investors: GlaxoSmithKline plc (NYSE:GSK)
Many analysts have provided their estimated foresights on GlaxoSmithKline plc Earnings, with 2 analysts believing the company would generate an Average Estimate of $0.63.
Mast Therapeutics Inc (NYSEMKT:MSTX) & GlaxoSmithKline plc (ADR) (NYSE:GSK ...
On Friday, Shares of Mast Therapeutics Inc (NYSEMKT:MSTX) lost -2.00% to $0.137. The share price is trading in a range of $0.13 - 0.14.
Brick & Kyle Associates Has $1834000 Position in GlaxoSmithKline PLC (GSK)
GlaxoSmithKline PLC logo Brick & Kyle Associates increased its position in shares of GlaxoSmithKline PLC (NYSE:GSK) by 6.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission.